Close



Nov 9, 2023 07:30AM
Jul 2, 2021 04:01PM
Jun 30, 2021 05:00AM
Jun 29, 2021 09:08PM
Jun 28, 2021 04:02PM
Jun 28, 2021 04:01PM
May 6, 2021 07:30AM Intellia Therapeutics Announces First Quarter 2021 Financial Results
Dec 4, 2020 04:01PM
Dec 2, 2020 06:04AM
Dec 1, 2020 09:30PM
Nov 30, 2020 04:01PM
Nov 30, 2020 04:01PM
Jun 5, 2020 04:01PM
Jun 3, 2020 05:54AM Intellia Therapeutics (NTLA) Prices 5.48M Share Common Offering at $18.25/Sh
Jun 2, 2020 09:00PM
Jun 1, 2020 04:01PM
Jun 1, 2020 04:00PM
Sep 30, 2019 08:00AM
May 30, 2019 04:30PM
Nov 8, 2018 04:30PM
Aug 27, 2018 08:00AM Intellia Therapeutics to Present at September Healthcare Investor Conferences
Jan 9, 2018 07:29AM
Nov 2, 2017 04:30PM
Nov 2, 2017 05:48AM
Nov 1, 2017 09:00PM
Nov 1, 2017 07:48AM
Nov 1, 2017 07:13AM
Nov 1, 2017 07:00AM Intellia Therapeutics Announces Proposed Public Offering of Common Stock
Oct 3, 2017 04:35PM
Jul 20, 2017 08:18AM
Jun 22, 2017 06:58AM
Feb 8, 2017 07:50AM
Nov 1, 2016 04:05PM
Oct 31, 2016 07:00AM
Oct 5, 2016 07:00AM Intellia Therapeutics to Present at Jefferies Gene Editing/Therapy Summit
Aug 5, 2016 09:20AM
Aug 5, 2016 07:14AM
Jun 3, 2016 04:03PM
May 31, 2016 07:03AM
May 11, 2016 04:05PM
May 6, 2016 10:33AM
May 6, 2016 09:46AM Intellia Therapeutics (NTLA) IPO Set to Open After Pricing at $18
May 5, 2016 07:02PM

56,435 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All